Showing results (11-20 of 106) with videos related to
Sort By:
Pageof 11
Journal of Nutritional Science|November 15, 2023
Barriers and facilitators of healthy lifestyle and perspectives towards the development of weight loss programmes. Focus groups with post-treatment breast cancer survivors in GreeceMaria Perperidi, Georgios Saltaouras, Alexandros Konstandis, et al.Cancers|October 14, 2022
Significant Rise of Colorectal Cancer Incidence in Younger Adults and Strong Determinants: 30 Years Longitudinal Differences between under and over 50sDimitra Sifaki-Pistolla, Viktoria Poimenaki, Ilektra Fotopoulou, et al.Frontiers in Immunology|October 16, 2018
Lymph Node Cellular Dynamics in Cancer and HIV: What Can We Learn for the Follicular CD4 (Tfh) Cells?Antigoni Poultsidi, Yiannis Dimopoulos, Ting-Fang He, et al.Molecular and Cellular Endocrinology|October 25, 2011
The cAMP pathway and the control of adrenocortical development and growthCyrille de Joussineau, Isabelle Sahut-Barnola, Isaac Levy, et al.Healthcare (Basel, Switzerland)|July 29, 2025
Formative Development and Acceptability of a Lifestyle Weight Management Intervention for Breast Cancer Survivors in Greece: The NutriLife StudyMaria Perperidi, Eleni Skeparnakou, Dimitra Strongylou, et al.Journal of Clinical Medicine|July 15, 2026
Characterizing Gynecological Cancers with the Uncommon dMMR/MSS Phenotype in Lynch Syndrome PatientsGeorgios Koktsidis, Davide Mauri, Stylianos Elemes, et al.Scandinavian Journal of Infectious Diseases|April 18, 2008
Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: an analysis of microbiological dataGeorge Samonis, Diamantis P Kofteridis, Emmanouil Saloustros, et al.Breast Cancer Research : BCR|June 14, 2011
Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapseEmmanouil Saloustros, Maria Perraki, Stella Apostolaki, et al.Clinical Breast Cancer|November 21, 2017
Weekly Paclitaxel and Carboplatin Plus Bevacizumab as First-Line Treatment of Metastatic Triple-Negative Breast Cancer. A Multicenter Phase II Trial by the Hellenic Oncology Research GroupEmmanouil Saloustros, Michail Nikolaou, Konstantinos Kalbakis, et al.Breast Cancer Research and Treatment|January 17, 2018
Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancerFlorentia Fostira, Emmanouil Saloustros, Paraskevi Apostolou, et al.Pageof 11